Metabolic impairment in heart failure: The myocardial and systemic perspective

Wolfram Doehner, Michael Frenneaux, Stefan D. Anker

Research output: Contribution to journalArticle

Abstract

Although bioenergetic starvation is not a new concept in heart failure (HF), recent research has led to a growing appreciation of the complexity of metabolic aspects of HF pathophysiology. All steps of energy extraction, transfer, and utilization are affected, and structural metabolism is impaired, leading to compromised functional integrity of tissues. Not only the myocardium, but also peripheral tissues and organs are affected by metabolic failure, resulting in a global imbalance between catabolic and anabolic signals, leading to tissue wasting and, ultimately, to cachexia. Metabolic feedback signals from muscle and fat actively contribute to further myocardial strain, promoting disease progression. The prolonged survival of patients with stable, compensated HF will increasingly bring chronic metabolic complications of HF to the fore and gradually shift its clinical presentation. This paper reviews recent evidence on myocardial and systemic metabolic impairment in HF and summarizes current and emerging therapeutic concepts with specific metabolic targets.

Original languageEnglish
Pages (from-to)1388-1400
Number of pages13
JournalJournal of the American College of Cardiology
Volume64
Issue number13
DOIs
Publication statusPublished - Sep 30 2014

Fingerprint

Heart Failure
Cachexia
Energy Transfer
Starvation
Energy Metabolism
Disease Progression
Myocardium
Fats
Muscles
Survival
Research
Therapeutics

Keywords

  • cachexia
  • insulin resistance
  • metabolism
  • muscle
  • sarcopenia
  • stroke

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Metabolic impairment in heart failure : The myocardial and systemic perspective. / Doehner, Wolfram; Frenneaux, Michael; Anker, Stefan D.

In: Journal of the American College of Cardiology, Vol. 64, No. 13, 30.09.2014, p. 1388-1400.

Research output: Contribution to journalArticle

Doehner, Wolfram ; Frenneaux, Michael ; Anker, Stefan D. / Metabolic impairment in heart failure : The myocardial and systemic perspective. In: Journal of the American College of Cardiology. 2014 ; Vol. 64, No. 13. pp. 1388-1400.
@article{6a2bd8ed9ca1430db062bc2bac5421fe,
title = "Metabolic impairment in heart failure: The myocardial and systemic perspective",
abstract = "Although bioenergetic starvation is not a new concept in heart failure (HF), recent research has led to a growing appreciation of the complexity of metabolic aspects of HF pathophysiology. All steps of energy extraction, transfer, and utilization are affected, and structural metabolism is impaired, leading to compromised functional integrity of tissues. Not only the myocardium, but also peripheral tissues and organs are affected by metabolic failure, resulting in a global imbalance between catabolic and anabolic signals, leading to tissue wasting and, ultimately, to cachexia. Metabolic feedback signals from muscle and fat actively contribute to further myocardial strain, promoting disease progression. The prolonged survival of patients with stable, compensated HF will increasingly bring chronic metabolic complications of HF to the fore and gradually shift its clinical presentation. This paper reviews recent evidence on myocardial and systemic metabolic impairment in HF and summarizes current and emerging therapeutic concepts with specific metabolic targets.",
keywords = "cachexia, insulin resistance, metabolism, muscle, sarcopenia, stroke",
author = "Wolfram Doehner and Michael Frenneaux and Anker, {Stefan D.}",
year = "2014",
month = "9",
day = "30",
doi = "10.1016/j.jacc.2014.04.083",
language = "English",
volume = "64",
pages = "1388--1400",
journal = "Journal of the American College of Cardiology",
issn = "0735-1097",
publisher = "Elsevier USA",
number = "13",

}

TY - JOUR

T1 - Metabolic impairment in heart failure

T2 - The myocardial and systemic perspective

AU - Doehner, Wolfram

AU - Frenneaux, Michael

AU - Anker, Stefan D.

PY - 2014/9/30

Y1 - 2014/9/30

N2 - Although bioenergetic starvation is not a new concept in heart failure (HF), recent research has led to a growing appreciation of the complexity of metabolic aspects of HF pathophysiology. All steps of energy extraction, transfer, and utilization are affected, and structural metabolism is impaired, leading to compromised functional integrity of tissues. Not only the myocardium, but also peripheral tissues and organs are affected by metabolic failure, resulting in a global imbalance between catabolic and anabolic signals, leading to tissue wasting and, ultimately, to cachexia. Metabolic feedback signals from muscle and fat actively contribute to further myocardial strain, promoting disease progression. The prolonged survival of patients with stable, compensated HF will increasingly bring chronic metabolic complications of HF to the fore and gradually shift its clinical presentation. This paper reviews recent evidence on myocardial and systemic metabolic impairment in HF and summarizes current and emerging therapeutic concepts with specific metabolic targets.

AB - Although bioenergetic starvation is not a new concept in heart failure (HF), recent research has led to a growing appreciation of the complexity of metabolic aspects of HF pathophysiology. All steps of energy extraction, transfer, and utilization are affected, and structural metabolism is impaired, leading to compromised functional integrity of tissues. Not only the myocardium, but also peripheral tissues and organs are affected by metabolic failure, resulting in a global imbalance between catabolic and anabolic signals, leading to tissue wasting and, ultimately, to cachexia. Metabolic feedback signals from muscle and fat actively contribute to further myocardial strain, promoting disease progression. The prolonged survival of patients with stable, compensated HF will increasingly bring chronic metabolic complications of HF to the fore and gradually shift its clinical presentation. This paper reviews recent evidence on myocardial and systemic metabolic impairment in HF and summarizes current and emerging therapeutic concepts with specific metabolic targets.

KW - cachexia

KW - insulin resistance

KW - metabolism

KW - muscle

KW - sarcopenia

KW - stroke

UR - http://www.scopus.com/inward/record.url?scp=84908294192&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84908294192&partnerID=8YFLogxK

U2 - 10.1016/j.jacc.2014.04.083

DO - 10.1016/j.jacc.2014.04.083

M3 - Article

C2 - 25257642

AN - SCOPUS:84908294192

VL - 64

SP - 1388

EP - 1400

JO - Journal of the American College of Cardiology

JF - Journal of the American College of Cardiology

SN - 0735-1097

IS - 13

ER -